These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 20207364

  • 1. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
    Pires I, Garcia A, Prada J, Queiroga FL.
    J Comp Pathol; 2010; 143(2-3):142-9. PubMed ID: 20207364
    [Abstract] [Full Text] [Related]

  • 2. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
    Cuitiño MC, Massone AR, Idiart JR.
    J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma.
    de Souza do Nascimento J, Carlos R, Delgado-Azañero W, Mosqueda Taylor A, de Almeida OP, Romañach MJ, de Andrade BA.
    J Oral Pathol Med; 2016 Jul; 45(6):440-3. PubMed ID: 26608958
    [Abstract] [Full Text] [Related]

  • 4. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL, Alves A, Pires I, Lopes C.
    J Comp Pathol; 2007 Jul; 136(2-3):177-85. PubMed ID: 17416236
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of tenascin in melanocytic tumours of dogs.
    Sevastre B, van Ederen AM, Terlou M, Gruys E, Nederbragt H.
    J Comp Pathol; 2007 Jan; 136(1):49-56. PubMed ID: 17258226
    [Abstract] [Full Text] [Related]

  • 6. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms.
    Martínez CM, Peñafiel-Verdú C, Vilafranca M, Ramírez G, Méndez-Gallego M, Buendía AJ, Sánchez J.
    Vet Pathol; 2011 Nov; 48(6):1204-11. PubMed ID: 21292918
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of cyclooxygenase-2 expression in canine mast cell tumours.
    Prada J, Queiroga FL, Gregório H, Pires I.
    J Comp Pathol; 2012 Jul; 147(1):31-6. PubMed ID: 22079567
    [Abstract] [Full Text] [Related]

  • 8. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
    Shimoyama Y, Akihara Y, Kirat D, Iwano H, Hirayama K, Kagawa Y, Ohmachi T, Matsuda K, Okamoto M, Kadosawa T, Yokota H, Taniyama H.
    Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
    Silveira TL, Veloso ES, Gonçalves INN, Costa RF, Rodrigues MA, Cassali GD, Del Puerto HL, Pang LY, Argyle DJ, Ferreira E.
    Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
    [Abstract] [Full Text] [Related]

  • 10. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
    Chwirot BW, Kuźbicki Ł.
    Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
    [Abstract] [Full Text] [Related]

  • 11. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
    Yamada N, Mori T, Murakami M, Noguchi S, Sakai H, Akao Y, Maruo K.
    Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
    [Abstract] [Full Text] [Related]

  • 12. Expression of cyclooxygenase-2 in canine uveal melanocytic neoplasms.
    Paglia D, Dubielzig RR, Kado-Fong HK, Maggs DJ.
    Am J Vet Res; 2009 Oct; 70(10):1284-90. PubMed ID: 19795944
    [Abstract] [Full Text] [Related]

  • 13. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
    Kuźbicki L, Sarnecka A, Chwirot BW.
    Melanoma Res; 2006 Feb; 16(1):29-36. PubMed ID: 16432453
    [Abstract] [Full Text] [Related]

  • 14. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
    Cangul IT, van Garderen E, van der Linde-Sipman JS, van den Ingh TS, Schalken JA.
    J Comp Pathol; 2001 Feb; 125(2-3):166-73. PubMed ID: 11578133
    [Abstract] [Full Text] [Related]

  • 15. C-kit expression in canine mucosal melanomas.
    Newman SJ, Jankovsky JM, Rohrbach BW, LeBlanc AK.
    Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
    [Abstract] [Full Text] [Related]

  • 16. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z, Jasani B, Haywood S, Mullins JE, Fuentealba IC.
    J Comp Pathol; 2001 Sep; 125(2-3):130-6. PubMed ID: 11578128
    [Abstract] [Full Text] [Related]

  • 17. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
    Sedghizadeh PP, Williams JD, Allen CM, Prasad ML.
    Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
    [Abstract] [Full Text] [Related]

  • 18. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
    Roels S, Tilmant K, Ducatelle R.
    J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
    [Abstract] [Full Text] [Related]

  • 19. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
    Kuźbicki Ł, Lange D, Strączyńska-Niemiec A, Chwirot BW.
    Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
    [Abstract] [Full Text] [Related]

  • 20. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
    Millanta F, Fratini F, Corazza M, Castagnaro M, Zappulli V, Poli A.
    Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.